Year (N) | Pfdhfr gene SNPs | Pfdhps gene SNPs | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
51I | 59R | 108 N | 437G | 540E | 581G | |||||||
N (%) | 95% CI | N (%) | 95% CI | N (%) | 95% CI | N (%) | 95% CI | N (%) | 95% CI | N (%) | 95%CI | |
1999 (N = 60) | 51 (58%) | 88.64–99.08 | 56 (93.3%) | 84.07–97.38 | 56 (93.3%) | 88.64–99.08 | 30 (50%) | 37.74–62.24 | 4 (6.6%) | 2.62–15.93 | 3 (5%) | 1.71–13-70 |
2001 (N = 102) | 95 (93.1%) | 86.51–96.64 | 88 (86.3%) | 78.27–91.64 | 83 (81.4%) | 72.73–87.74 | 62 (60.7%) | 51.08–69.70 | 0 | 0–3.63 | 0 | 0–3.63 |
2004/5 (N = 262) | 255 (93.3%) | 94.59–98.70 | 259 (98.8%) | 96.69–99.61 | 257 (98.1%) | 95.61–99.18 | 158 (60.3%) | 54.27–66.04 | 0 | 0–3.63 | 0 | 0–3.63 |
2006 (N = 158) | 150 (94.9%) | 90.33–97.41 | 151 (95.5%) | 91.14–97.84 | 158 (100%) | 97.63–100 | 44 (27.8%) | 21.45–35.3 | 4 (2.5%) | 0.99–6.33 | 0 | 0–2.37 |
2011 (N = 163) | 159 (97.5%) | 93.86–99.04 | 159 (97.5%) | 93.86–99.04 | 163 (100%) | 97.7–100 | 136 (93.4%) | 76.97–88.36 | 9 (5.5%) | 2.93–10.16 | 3 (1.8%) | 0.63–5.27 |
2013 (N = 170) | 168 (98.8%) | 95.81–99.68 | 167 (98.2%) | 94.94–99.4 | 168 (98.8%) | 95.81–99.68 | 149 (87.6%) | 81.85–91.78 | 26 (15.3%) | 10.66–21.47 | 1 (0.58%) | 0.10–3.26 |
2016 (N = 169) | 169 (100%) | 97.78–100 | 149 (88.2%) | 82.43–92.21 | 168 (98.8%) | 95.81–99.68 | 156 (92.3%) | 87.29–95.45 | 23 (13.6%) | 9.24–19.59 | 5 (3%) | 1.27–6.74 |
2019 (N = 139) | 135 (97.1%) | 92.83–98.88 | 131 (94.2%) | 89.05–97.06 | 139 (100%) | 97.31–100 | 130 (93.5%) | 88.15–96.56 | 51 (36.6%) | 29.14–44.96 | 2 (1.4%) | 0.4–5.09 |
p-value | 4.9e−7 | 7e− | 0 | 0 | 0 | 0.0053 |